Clobazam API Micronized from Japan
Micronized Active Pharmaceutical Ingredient (API) form of Clobazam for improved bioavailability in tablet formulations. As a pure chemically defined heterocyclic nitrogen compound (lactam), it qualifies under HTS 2933.72.00.00. Used exclusively as intermediate for epilepsy treatment medications.
Duty Rate — Japan → United States
27.5%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.4912.5%Except for products described in headings 9903.05.85–9903.05.92, articles the product of Japan, with an ad valorem (or ad valorem equivalent) rate of duty under column 1 less than 12.5 percent, as provided for in U.S. note 52 to this subchapter
Import Tips
• Include particle size distribution analysis in technical documentation to justify micronized form for manufacturing use
• Pre-register with FDA Drug Master File (DMF) system before import to streamline clearance for API shipments
• Avoid retail packaging; use industrial bulk drums to prevent misclassification as finished dosage form